In 1972, Rosai and Higa first described primary neuroendocrine tumours of the thymus (NETT). Prior to that, all epithelial tumours of the thymus were referred as epithelial thymomas. 1 These tumours are considered rare and constitute approximately 0.4% of all carcinoid tumours. Surveillance, Epidemiology and End Results (SEER) database shows the incidence of NETT to be 0.02/100,000 person per year. 2 According to the World Health Organization classification of thymic tumours 2015, these tumours are divided into 2 major groups which are well differentiated and neuroendocrine carcinomas. They are fur-